Clinical Trial Update: Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oral rucaparib in combination with other anticancer agents in metastatic castration-resistant prostate cancer has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: pharmaand GmbH | Conditions: Metastatic Castration Resistant Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2023-06-28